Metaanalysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinoma

Cancer

Volumn 104, Issue 1, 2005, Pages 94-100

  Wiegand, Susanne ^a   Dünne, Anja A ^a   Müller, Helge H ^a   Mandic, Robert ^a   Barth, Peter ^a   Davis, Ronald K ^b   Werner, Jochen A ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Lymph node metastases; Matrix metalloproteinases; Metaanalysis; Squamous cell carcinoma

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE 14; STROMELYSIN;

CANCER STAGING; CLINICAL TRIAL; HEAD AND NECK CARCINOMA; HUMAN; LYMPHADENOPATHY; META ANALYSIS; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION;

CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; RISK FACTORS;

EID: 20544456398     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21131     Document Type: Review

References (20)

1. Shingaki S, Suzuki I, Kobayashi T, Nakajima T. Predicting factors for distant metastasis in head and neck carcinomas: an analysis of 103 patients with locoregional control. J Oral Maxillofac Surg. 1996;54:853-857.
2. Helliwell TR. Molecular markers of metastasis in squamous cell carcinomas. J Pathol. 2001;194:289-293.
3. Werner JA, Rathcke IO, Mandic R. The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck. Clin Exp Metast. 2002;19:275-282.
4. Whitehead A, Whitehead J. A general parametic approach to the metaanalysis of randomized clinical trials. Stat Med. 1991;10:1665-1677.
5. Zelen M. The analysis of several 2 × 2 contingency tables. Biometrika. 1971;58:129-137.
6. Mehta CR, Patel NR, Gray R. On computing an exact confidence interval for the common odds ratio in several 2 × 2 contingency tables. J Am Stat Assoc. 1985;80:969-973.
7. Kurahara S, Shinohara M, Ikebe T, et al. Expression of MMPs, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck. 1999;21:627-638.
8. Sawatsubashi M, Hiroyuki M, Tokunaga O, Shin T. Expression of MMP-1, TIMP-1, and Type I collagen in laryngeal carcinoma. Mod Pathol. 1998;11:878-885.
9. Hong SD, Hong SP, Lee JI, Lim CY. Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential. Oral Oncol. 2000;36:207-213.
10. Imanishi Y, Fujii M, Tokumaru Y, et al. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Hum Pathol. 2000;31:895-904.
11. Krecicki T, Zalesska-Krecicka M, Jelen M, Szkudlarek T, Horobiowska M. Expression of Type IV collagen and matrix metalloproteinase-2 (Type IV collagenase) in relation to nodal status in laryngeal cancer. Clin Otolaryngol. 2001;26:469-472.
12. Kusukawa J, Sasaguri Y, Shima I, Kameyama T, Morimatsu M. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. Am J Clin Pathol. 1993;99:18-23.
13. Repassy G, Forster-Horvath C, Juhasz A, Adany R, Tamassy A, Timar J. Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma. Pathol Oncol Res. 1998;4:14-21.
14. Yoshizaki T, Maruyama Y, Sato H, Furukawa M. Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Int J Cancer. 2001;95:44-50.
15. Kusukawa J, Sasaguri Y, Morimatsu M, Kameyama T. Expression of matrix metalloproteinase-3 in Stage I and Stage II squamous cell carcinoma of the oral cavity. J Oral Maxillofac Surg. 1995;53:530-534.
16. Kusukawa J, Harada H, Shima I, Sasaguri Y, Kameyama T, Morimatsu M. The significance of epidermal growth factor receptor and matrix metalloproteinase-3 in squamous cell carcinoma of the oral cavity. Eur J Cancer B Oral Oncol. 1996;32B:217-221.
17. Franchi A, Santucci M, Masini E, Sardi I, Paglierani M, Gallo O. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer. 2002;95:1902-1910.
18. Horikawa T, Yoshizaki T, Sheen TS, Lee SY, Furukawa M. Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer. 2000;89:715-723.
19. Riedel F, Götte K, Schwalb J, Bergler W, Hörmann K. Expression of 92-kDa Type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma. Int J Oncol. 2000;17:1099-1105.
20. Yoshizaki T, Sato H, Maruyama Y, et al. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer. 1997;79:139-144.